About Christopher Thorne
Form D filings for Cytonus Therapeutics from 2021 to 2023 list Christopher Thorne as director.
Christopher Thorne first appears on SEC filings in 2021.
Experience
This experience comes from SEC filings. The years are when the filings name Christopher Thorne in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Christopher Thorne works with at each company, as listed on that company's latest Form D.
Cytonus Therapeutics, Inc. · Form D, Nov 6, 2023
RM
Remo Moomiaie
Chief Executive Officer and director
RK
Richard Klemke
Executive officer and director
JA
Jae An
Director